Evidence map›Paper›PMID 23698792›Full record

ArticleChemical communications (Cambridge, England)2013

Dual recognition of the human telomeric G-quadruplex by a neomycin-anthraquinone conjugate.

Nihar Ranjan, Erik Davis, Liang Xue, Dev P Arya

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. An assay for human telomeric G-quadruplex DNA binding drugs.Bioorganic & medicinal chemistry letters · 2013
    Article
  18. Article
  19. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.Bioorganic & medicinal chemistry letters · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nihar RanjanLaboratory of Bioorganic and Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, SC 29634, USA.
Erik Davis
Liang Xue
Dev P Arya

Funding

Development of Ets2-InhibitorsR15CA125724 · NCI · CLEMSON UNIVERSITY · PI ARYA, DEV PRIYA · 2008 to 2009
$398k
A novel assay for RNA targeted drugsR41GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2011 to 2011
$286k
NCI NIH HHS 15CA125724NCI NIH HHS R15 CA125724NIGMS NIH HHS R41 GM097917NIGMS NIH HHS R41GM097917
6 · The paper itself

Abstract

The authors report the recognition of a G-quadruplex formed by four repeat human telomeric DNA with aminosugar intercalator conjugates. The recognition of the G-quadruplex through dual binding mode ligands significantly increased the affinity of ligands for the G-quadruplex. One such example is a neomycin-anthraquinone conjugate (2) which exhibited nanomolar affinity for the quadruplex, and the affinity of (2) is nearly 1000 fold higher for the human telomeric G-quadruplex DNA than its constituent units, neomycin and anthraquinone.

Indexed as

G-QuadruplexesAnthraquinonesBinding SitesCircular DichroismHumansIntercalating AgentsLigandsNeomycinNucleic Acid DenaturationPhase TransitionTelomereTransition TemperatureUltraviolet Rays9,10-anthraquinoneAnthraquinonesIntercalating AgentsLigandsNeomycin

Identifiers

PMID23698792
PMCPMC3977216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.